Catalyst
Slingshot members are tracking this event:
FDA Expands IMBRUVICA Label to Include New Data from Two Key Phase 3 Trials, Adding Overall Survival and Combination Data
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 09, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Resonate-2, Imbruvica, Rituximab, Bendamustine, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
